-

Schrödinger to Participate in Upcoming Investor Conferences

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in the following conferences in May:

  • BofA Securities 2026 Healthcare Conference: Fireside chat on Wednesday, May 13, 2026, at 5:20 p.m. E.T.
  • RBC 2026 Global Healthcare Conference: Fireside chat on Tuesday, May 19, 2026 at 2:05 p.m. E.T.

The live discussions can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approximately 90 days following the event.

About Schrödinger
Schrödinger is transforming molecular discovery with its computational platform, which enables the discovery of novel, highly optimized molecules for drug development and materials design. Schrödinger’s software platform is built on more than 30 years of R&D investment and is licensed by biotechnology, pharmaceutical and industrial companies, and academic institutions around the world. Schrödinger also leverages the platform to advance a portfolio of collaborative and internal programs. Founded in 1990, Schrödinger has approximately 800 employees operating from 15 locations globally. To learn more, visit www.schrodinger.com, follow us on LinkedIn, or visit our blog, Extrapolations.com.

Contacts

Matthew Luchini
Schrödinger, Inc.
matthew.luchini@schrodinger.com
917-719-0636

Schrödinger

NASDAQ:SDGR

Release Versions

Contacts

Matthew Luchini
Schrödinger, Inc.
matthew.luchini@schrodinger.com
917-719-0636

More News From Schrödinger

Schrödinger Reports Second Quarter 2026 Financial Results

NEW YORK--(BUSINESS WIRE)--Today Schrödinger announced financial results for the quarter ended June 30, 2026....

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. announced a strategic agreement with BMS to deploy Bunsen, Schrödinger's agentic AI co-scientist, within its research organization....

Schrödinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. today announced the launch of its early access version of Bunsen, its new agentic AI co-scientist....
Back to Newsroom